127 related articles for article (PubMed ID: 35480921)
1. Synthesis and biological evaluation of novel artemisone-piperazine-tetronamide hybrids.
Wei MX; Yu JY; Liu XX; Li XQ; Yang JH; Zhang MW; Yang PW; Zhang SS; He Y
RSC Adv; 2021 May; 11(30):18333-18341. PubMed ID: 35480921
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of artemisinin-piperazine-furan ether hybrids and evaluation of in vitro cytotoxic activity.
Wei MX; Yu JY; Liu XX; Li XQ; Zhang MW; Yang PW; Yang JH
Eur J Med Chem; 2021 Apr; 215():113295. PubMed ID: 33636536
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, and Biological Evaluation of Artemisinin-Piperazine-Phosphoramide Mustard Hybrids as Potential Anticancer Agents.
Wei MX; Zhang SS; Sun X; Ji Y; Yang PW; Li XQ
ChemMedChem; 2022 Sep; 17(17):e202200239. PubMed ID: 35771689
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of rhein-piperazine-furanone hybrids as potential anticancer agents.
He Y; Zhang SS; Wei MX
RSC Med Chem; 2024 Mar; 15(3):848-855. PubMed ID: 38516604
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis and Anti-Lung Cancer Evaluation of 1, 2, 3-Triazole Tethered Dihydroartemisinin-Isatin Hybrids.
Hou H; Qu B; Su C; Hou G; Gao F
Front Pharmacol; 2021; 12():801580. PubMed ID: 34975498
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activities of dithiocarbamates containing 2(5H)-furanone-piperazine.
Wei MX; Zhang J; Ma FL; Li M; Yu JY; Luo W; Li XQ
Eur J Med Chem; 2018 Jul; 155():165-170. PubMed ID: 29886320
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological activities of artemisinin-piperazine-dithiocarbamate derivatives.
Yu JY; Li XQ; Wei MX
Eur J Med Chem; 2019 May; 169():21-28. PubMed ID: 30852384
[TBL] [Abstract][Full Text] [Related]
8. Three-Carbon Linked Dihydroartemisinin-Isatin Hybrids: Design, Synthesis and Their Antiproliferative Anticancer Activity.
Dong M; Zheng G; Gao F; Li M; Zhong C
Front Pharmacol; 2022; 13():834317. PubMed ID: 35153798
[TBL] [Abstract][Full Text] [Related]
9. Facile Preparation of
Wu Y; Parapini S; Williams ID; Misiano P; Wong HN; Taramelli D; Basilico N; Haynes RK
Molecules; 2018 Jul; 23(7):. PubMed ID: 30011856
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of thiadiazolo-carboxamide bridged β-carboline-indole hybrids: DNA intercalative topo-IIα inhibition with promising antiproliferative activity.
Tokala R; Sana S; Lakshmi UJ; Sankarana P; Sigalapalli DK; Gadewal N; Kode J; Shankaraiah N
Bioorg Chem; 2020 Dec; 105():104357. PubMed ID: 33091673
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of a series of novel dihydroartemisinin monomers and dimers containing chalcone as a linker and their anticancer activity.
Gaur R; Pathania AS; Malik FA; Bhakuni RS; Verma RK
Eur J Med Chem; 2016 Oct; 122():232-246. PubMed ID: 27371926
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of some novel 1,2,3-triazole hybrids of myrrhanone B isolated from Commiphora mukul gum resin: Identification of potent antiproliferative leads active against prostate cancer cells (PC-3).
Madasu C; Karri S; Sangaraju R; Sistla R; Uppuluri MV
Eur J Med Chem; 2020 Feb; 188():111974. PubMed ID: 31883489
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Anticancer Activity of a Bile Acid-Dihydroartemisinin Hybrid Ursodeoxycholic-Dihydroartemisinin in Hepatocellular Carcinoma Cells.
Huang TE; Deng YN; Hsu JL; Leu WJ; Marchesi E; Capobianco ML; Marchetti P; Navacchia ML; Guh JH; Perrone D; Hsu LC
Front Pharmacol; 2020; 11():599067. PubMed ID: 33343369
[TBL] [Abstract][Full Text] [Related]
14. Efficient new constructs against triple negative breast cancer cells: synthesis and preliminary biological study of ferrocifen-SAHA hybrids and related species.
Cázares Marinero Jde J; Lapierre M; Cavaillès V; Saint-Fort R; Vessières A; Top S; Jaouen G
Dalton Trans; 2013 Nov; 42(43):15489-501. PubMed ID: 24030275
[TBL] [Abstract][Full Text] [Related]
15. Optimal 10-Aminoartemisinins With Potent Transmission-Blocking Capabilities for New Artemisinin Combination Therapies-Activities Against Blood Stage
Wong HN; Padín-Irizarry V; van der Watt ME; Reader J; Liebenberg W; Wiesner L; Smith P; Eribez K; Winzeler EA; Kyle DE; Birkholtz LM; Coertzen D; Haynes RK
Front Chem; 2019; 7():901. PubMed ID: 31998692
[TBL] [Abstract][Full Text] [Related]
16. Novel 2-indolinone thiazole hybrids as sunitinib analogues: Design, synthesis, and potent VEGFR-2 inhibition with potential anti-renal cancer activity.
Mahmoud HK; Farghaly TA; Abdulwahab HG; Al-Qurashi NT; Shaaban MR
Eur J Med Chem; 2020 Dec; 208():112752. PubMed ID: 32947227
[TBL] [Abstract][Full Text] [Related]
17. Cross-resistance to cytosine arabinoside in human acute myeloid leukemia cells selected for resistance to vincristine.
Baran Y; Gunduz U; Ural AU
Exp Oncol; 2006 Jun; 28(2):163-5. PubMed ID: 16837911
[TBL] [Abstract][Full Text] [Related]
18. Design and in Vitro Characterization of Tricyclic Benzodiazepine Derivatives as Potent and Selective Antileukemic Agents.
Mieczkowski A; Frączyk T; Psurski M; Wińska P; Siedlecki P; Dziełak M; Trzybiński D; Wilczek M; Bagiński M; Bieszczad B; Woźniak K
Chem Biodivers; 2021 Jan; 18(1):e2000733. PubMed ID: 33236468
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of quinoline-pyrimidine inspired hybrids as potential plasmodial inhibitors.
Kayamba F; Malimabe T; Ademola IK; Pooe OJ; Kushwaha ND; Mahlalela M; van Zyl RL; Gordon M; Mudau PT; Zininga T; Shonhai A; Nyamori VO; Karpoormath R
Eur J Med Chem; 2021 May; 217():113330. PubMed ID: 33744688
[TBL] [Abstract][Full Text] [Related]
20. New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-trioxane-ferrocene hybrids.
Reiter C; Fröhlich T; Zeino M; Marschall M; Bahsi H; Leidenberger M; Friedrich O; Kappes B; Hampel F; Efferth T; Tsogoeva SB
Eur J Med Chem; 2015 Jun; 97():164-72. PubMed ID: 25965779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]